Cadence Pharmaceuticals Announces Strategic Plan to Secure Long-Term Manufacture and Supply of OFIRMEV® (acetaminophen) Injection

[PR Newswire] – SAN DIEGO, March 6, 2013 /PRNewswire/ — Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products … more

View todays social media effects on GRF

View the latest stocks trending across Twitter. Click to view dashboard

See who Eagle is hiring next, click here to view